Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril. [Phase 1]
Phase 1 trial evaluating dose proportionality of a fixed-dose combination of COREG CR (carvedilol CR) and lisinopril for hypertension; the s…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components [Phase 1]
A Phase 1 study evaluated whether the fixed-dose combination of COREG CR and Lisinopril is bioequivalent to taking the two components separa…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril. [Phase 1]
A Phase 1 study evaluated how food affects the pharmacokinetics of the fixed-dose combination of COREG CR (carvedilol CR) and lisinopril in …
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL. [Phase 1]
Phase 1 bioequivalence study comparing a fixed-dose combination tablet of COREG CR (carvedilol CR) with ZESTRIL (lisinopril) to taking COREG…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers [Phase 4]
A completed Phase 4 clinical trial evaluated the effects of nocturnal administration of antihypertensive medications in individuals who are …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' Losartan Potassium and Hydrochlorothiazide as a generic combination product for the treatment of hyperte…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical, Inc.'s Losartan Potassium as an original application generic, authorizing the same uses as the reference…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's generic losartan potassium and hydrochlorothiazide combination tablet for hypertension.
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet [Phase 3]
Phase 3 trial comparing the hemodynamic effects of the renin inhibitor aliskiren versus the ACE inhibitor captopril on renal function in hea…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for Losartan Potassium, a generic version of the hypertension medicine.
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved Quallent Pharmaceuticals Health LLC's generic Losartan Potassium under an original ANDA (ANDA078243).
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM 25 MG — Original Application (Strides Pharma Science Limited)
FDA approved Losartan Potassium 25 mg as an original ANDA by Strides Pharma Science Limited, making a generic version of losartan potassium …
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Losartan Potassium from Alembic Pharmaceuticals Limited, enabling a generic version for hypertension and r…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for losartan potassium (generic losartan potassium), an angiotensin II receptor…
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study [Phase 4]
Phase 4 randomized study comparing olmesartan with calcium antagonists in patients with hypertension and cardiovascular diseases; study stat…
-
FDA approval · 2010-10-04FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for PROCARDIA XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc, indicating changes under …
-
FDA approval · 2010-10-04FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride, a fixed-dose combination product manufactured …
-
CLINICAL_TRIALS research · 2010-10-01Clinical Trial Update: Using a Telemedicine System to Promote Patient Care Among Underserved Individuals [NA]
Temple University sponsors a clinical trial using a telemedicine system to improve care for underserved individuals with hypertension. The t…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure [Phase 4]
A Phase 4 dose-escalation trial evaluating a combination antihypertensive therapy in patients with hypertension who did not respond to singl…
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease [Phase 4]
A Phase 4 trial evaluating nebivolol in hypertensive patients with coronary artery disease has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-09-27Clinical Trial Update: Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension [Phase 3]
Phase 3 pharmacokinetic drug interaction study evaluating co-administration of valsartan, hydrochlorothiazide, and amlodipine in patients wi…
-
FDA approval · 2010-09-23FDA Approved: COZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Cozaar (losartan potassium) from Organon LLC.
-
FDA approval · 2010-09-23FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for clonidine hydrochloride from Unichem Pharmaceuticals (USA), Inc., confirming approval of the…
-
FDA approval · 2010-09-21FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR, a losartan potassium and hydrochlorothiazide combination, submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients [Phase 3]
Phase 3 trial update evaluating Nebivolol's vasodilatory effects in hypertensive patients; results have been posted.